Teladoc records $6.6B impairment charge on Livongo acquisition, spurring record net loss

Teladoc bought chronic care giant Livongo for $18.5 billion two years ago, but the asset’s waning value and external market factors triggered the massive goodwill impairment charge in the first quarter.